School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
Department of Psychiatry, Asst Monza, Italy.
Int J Neuropsychopharmacol. 2020 May 27;23(5):300-310. doi: 10.1093/ijnp/pyaa005.
This prospective cohort study aimed at evaluating patterns of polypharmacy and aggressive and violent behavior during a 1-year follow-up in patients with severe mental disorders.
A total of 340 patients (125 inpatients from residential facilities and 215 outpatients) were evaluated at baseline with the Structured Clinical Interview for DSM-IV Axis I and II, Brief Psychiatric Rating Scale, Specific Levels of Functioning scale, Brown-Goodwin Lifetime History of Aggression, Buss-Durkee Hostility Inventory, Barratt Impulsiveness Scale, and State-Trait Anger Expression Inventory-2. Aggressive behavior was rated every 15 days with the Modified Overt Aggression Scale and treatment compliance with the Medication Adherence Rating Scale.
The whole sample was prescribed mainly antipsychotics with high levels of polypharmacy. Clozapine prescription and higher compliance were associated with lower levels of aggressive and violent behavior. Patients with a history of violence who took clozapine were prescribed the highest number of drugs. The patterns of cumulative Modified Overt Aggression Scale mean scores of patients taking clozapine (n = 46), other antipsychotics (n = 257), and no antipsychotics (n = 37) were significantly different (P = .001). Patients taking clozapine showed a time trend at 1-year follow-up (24 evaluations) indicating a significantly lower level of aggressive behavior. Patient higher compliance was also associated with lower Modified Overt Aggression Scale ratings during the 1-year follow-up.
Both inpatients and outpatients showed high levels of polypharmacy. Clozapine prescription was associated with lower Modified Overt Aggression Scale ratings compared with any other antipsychotics or other psychotropic drugs. Higher compliance was associated with lower levels of aggressive and violent behavior.
本前瞻性队列研究旨在评估在为期 1 年的随访中,患有严重精神障碍的患者的多药治疗模式以及攻击和暴力行为模式。
共有 340 名患者(125 名住院患者来自住院设施,215 名门诊患者)在基线时接受 DSM-IV 轴 I 和 II 结构临床访谈、简要精神病评定量表、特定功能水平量表、Brown-Goodwin 终生攻击性史、Buss-Durkee 敌意量表、巴瑞特冲动量表和状态-特质愤怒表达量表-2 的评估。攻击性行为每隔 15 天使用改良显性攻击量表进行评定,治疗依从性使用药物依从性评定量表进行评定。
整个样本主要开抗精神病药且存在高水平的多药治疗。氯氮平的处方和更高的依从性与更低的攻击和暴力行为水平相关。曾有暴力史且服用氯氮平的患者开具的药物数量最多。服用氯氮平(n=46)、其他抗精神病药(n=257)和未服用抗精神病药(n=37)的患者累积改良显性攻击量表平均分数的模式存在显著差异(P=0.001)。服用氯氮平的患者在 1 年随访(24 次评估)时呈现出时间趋势,表明其攻击性行为水平显著降低。患者较高的依从性也与 1 年随访期间改良显性攻击量表的评分较低相关。
住院患者和门诊患者均显示出高水平的多药治疗。与任何其他抗精神病药或其他精神药物相比,氯氮平的处方与改良显性攻击量表评分较低相关。较高的依从性与较低的攻击和暴力行为水平相关。